- Trials with a EudraCT protocol (37)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
37 result(s) found for: Uncertainty.
Displaying page 1 of 2.
EudraCT Number: 2011-005494-22 | Sponsor Protocol Number: | Start Date*: 2012-06-21 | |||||||||||
Sponsor Name:University of Edinburgh [...] | |||||||||||||
Full Title: GaPP: A pilot randomised controlled trial of the efficacy and mechanism of action of gabapentin for the management of chronic pelvic pain in women | |||||||||||||
Medical condition: Chronic pelvic pain | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-003479-11 | Sponsor Protocol Number: 06/Q2604/75 | Start Date*: 2007-05-22 |
Sponsor Name:North Staffordshire Combined Healthcare Trust | ||
Full Title: The Stroke Oxygen Study. A randomised controlled study of the benefits and risks of routine oxygen treatment after acute stroke | ||
Medical condition: Acute Stroke | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (GB - no longer in EU/EEA) | ||
Trial results: (No results available) |
EudraCT Number: 2018-003652-21 | Sponsor Protocol Number: 2019-23 | Start Date*: 2020-01-23 | |||||||||||
Sponsor Name:OSPEDALE CLASSIFICATO EQUIPARATO SACRO CUORE DON CALABRIA - PRESIDIO OSPEDALIERO ACCREDITATO | |||||||||||||
Full Title: Interventional two arms open-label study for evaluating the diagnostic performance of PET PSMA in patients affected by biochemical recurrent prostate cancer. | |||||||||||||
Medical condition: Biochemical recurrent prostate cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-001317-15 | Sponsor Protocol Number: BAL2-2006 | Start Date*: 2006-05-09 |
Sponsor Name:University of Oxford | ||
Full Title: BALANCE 2: Bipolar disorder:Antidepressant/Lamotrigine/ANtipsychotic Comparative Evaluation | ||
Medical condition: Bipolar depression. | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2015-001481-25 | Sponsor Protocol Number: BorrSciWP2 | Start Date*: 2015-09-07 |
Sponsor Name:Sørlandet Sykehus HF | ||
Full Title: Lyme borreliosis; a scientific approach to reduce diagnostic and therapeutic uncertainties (BorrSci) WP2; SIX VERSUS TWO WEEKS TREATMENT WITH DOXYCYCLINE IN LYME NEUROBORRELIOSIS; A MULTICENTER,... | ||
Medical condition: Lyme Neuroborreliosis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NO (Completed) | ||
Trial results: View results |
EudraCT Number: 2006-002550-30 | Sponsor Protocol Number: DM/PR/5000/003/05 | Start Date*: 2006-11-09 |
Sponsor Name:Chiesi Farmaceutici S. p. A. | ||
Full Title: A randomized controlled pilot study for the comparison of efficacy of bronchoalveolar lavage (BAL) with Curosurf® in a dosage 50 mg/kg vs not treated control in adult patients affected by pulmonary... | ||
Medical condition: lung contusion | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) IT (Completed) | ||
Trial results: View results |
EudraCT Number: 2010-023505-36 | Sponsor Protocol Number: E2080-G000-303 | Start Date*: Information not available in EudraCT | |||||||||||
Sponsor Name:Eisai Ltd | |||||||||||||
Full Title: A Multicenter, Randomized, Controlled, Open-label Study to Evaluate the Cognitive Development Effects and Safety, and Pharmacokinetics of Adjunctive Rufinamide Treatment in Pediatric Subjects 1 to ... | |||||||||||||
Medical condition: Lennox Gastaut Syndrome | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) IT (Completed) GR (Completed) Outside EU/EEA | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-005271-15 | Sponsor Protocol Number: 20050179 | Start Date*: 2007-07-18 |
Sponsor Name:Amgen Inc | ||
Full Title: A Multicenter, Randomized Placebo Controlled Pilot MicroCT Study to Estimate the Effect of Treatment with Denosumab (AMG 162) and Alendronate Sodium in Postmenopausal Women with Low Bone Mineral De... | ||
Medical condition: Postmenopausal osteoporosis /osteopenia | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Female | |
Trial protocol: DE (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2013-005135-24 | Sponsor Protocol Number: ECDOPDEP2013 | Start Date*: 2014-03-21 | |||||||||||
Sponsor Name:Cristina Fernandez Pérez | |||||||||||||
Full Title: Clinical Trial crossed athletic population according UGT2B17 polymorphism. Impact on the steroid profile | |||||||||||||
Medical condition: Sports doping | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-011409-17 | Sponsor Protocol Number: LAST-RD - FARM77Z3BL | Start Date*: 2009-10-01 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA ISTITUTI OSPITALIERI DI VERONA | |||||||||||||
Full Title: Randomized evaluation of the effectiveness of lithium in subjects with treatment-resistant depression and suicide risk. An independent, pragmatic, multicentre, parallel-group, superiority trial. | |||||||||||||
Medical condition: Treatment-resistant depression and suicide risk. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-020302-15 | Sponsor Protocol Number: TOACT | Start Date*: 2011-10-14 | |||||||||||
Sponsor Name:IMM - Instituto de Medicina Molecular | |||||||||||||
Full Title: | |||||||||||||
Medical condition: Cerebral venous thrombosis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: PT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-006581-20 | Sponsor Protocol Number: HEMCML28 | Start Date*: 2022-05-11 | |||||||||||
Sponsor Name:Radboud univeristy medical centre | |||||||||||||
Full Title: A patient guided dose reduction strategy of tyrosine kinase inhibitors in chronic myeloid leukaemia: a prospective, multi-centre, non-randomised non-inferiority study. | |||||||||||||
Medical condition: Chronic myeloid leukaemia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-003669-14 | Sponsor Protocol Number: ISRCTN15088122 | Start Date*: 2012-12-03 | |||||||||||
Sponsor Name:London School Of Hygiene and Tropical Medicine | |||||||||||||
Full Title: Tranexamic Acid for the treatment of significant traumatic brain injury: an international, randomised, double blind, placebo controlled trial. | |||||||||||||
Medical condition: Traumatic Brain Injury | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) GB (Completed) IT (Completed) IE (Completed) SI (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-001823-30 | Sponsor Protocol Number: 043/SI | Start Date*: 2017-06-12 | |||||||||||
Sponsor Name:SIFI SpA | |||||||||||||
Full Title: Randomized, Assessor-Masked, Active-Controlled, Phase 3 Study to Evaluate Efficacy, Safety and Tolerability of 0.08% Polyhexamethylene Biguanide (PHMB) Ophthalmic Solution in Comparison with 0.02% ... | |||||||||||||
Medical condition: Acanthamoeba keratitis | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) PL (Completed) IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-010587-42 | Sponsor Protocol Number: 20080099 | Start Date*: 2009-09-17 | |||||||||||
Sponsor Name:Amgen Inc | |||||||||||||
Full Title: A Randomized Open-Label Study to Evaluate the Safety and Efficacy of Denosumab and Monthly Actonel® Therapies in Postmenopausal Women Transitioned from Weekly or Daily Alendronate Therapy. | |||||||||||||
Medical condition: Postmenopausal osteoporosis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: NL (Completed) GB (Completed) PT (Completed) DE (Completed) FR (Completed) AT (Completed) IT (Completed) IE (Completed) ES (Completed) GR (Completed) DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-004513-33 | Sponsor Protocol Number: OCTUMI-02 | Start Date*: 2008-05-08 | |||||||||||
Sponsor Name:University of Oxford | |||||||||||||
Full Title: Comparative Evaluation of QUEtiapine-Lamotrigine combination versus quetiapine monotherapy (and folic acid versus placebo) in patients with bipolar depression | |||||||||||||
Medical condition: Bipolar depression | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-000849-19 | Sponsor Protocol Number: 20050234 | Start Date*: 2006-10-27 |
Sponsor Name:Amgen Inc | ||
Full Title: A Randomized Study to Evaluate Safety and Efficacy of Transitioning Therapy From Alendronate to Denosumab (AMG 162) in Postmenopausal Women with Low Bone Mineral Density | ||
Medical condition: Postmenopausal Osteoporosis/osteopenia | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Female | |
Trial protocol: EE (Completed) PT (Prematurely Ended) IT (Completed) | ||
Trial results: View results |
EudraCT Number: 2021-006664-24 | Sponsor Protocol Number: INVEX-CLIN-IIH-301 | Start Date*: 2023-04-20 | |||||||||||
Sponsor Name:Invex Therapeutics Ltd. | |||||||||||||
Full Title: A Phase III randomised, placebo-controlled, double-blind, multi-centre, clinical trial to determine the efficacy and safety of Presendin in idiopathic intracranial hypertension | |||||||||||||
Medical condition: Idiopathic intracranial hypertension | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Prematurely Ended) DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2022-002312-23 | Sponsor Protocol Number: LY06006/MRCT-301 | Start Date*: 2023-05-25 | |||||||||||
Sponsor Name:Shandong Boan Biotechnology Co., Ltd. | |||||||||||||
Full Title: A randomized, double-blind, parallel-group, active-controlled comparative study to evaluate the efficacy, safety, pharmacokinetics, and immunogenicity of LY06006 compared with EU-Prolia in postmeno... | |||||||||||||
Medical condition: Postmenopausal osteoporosis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: BG (Trial now transitioned) CZ (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-002127-28 | Sponsor Protocol Number: 16016762 | Start Date*: 2016-07-19 | |||||||||||
Sponsor Name:Hvidovre University Hospital | |||||||||||||
Full Title: The impact of subcutaneous glucagon before, during and after exercise. A study in patients with type 1 diabetes mellitus | |||||||||||||
Medical condition: Patients with type 1 diabetes mellitus | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
